Quality of Life and Economic Burden in Swedish Adults with Atopic Dermatitis: A Cross-sectional Survey of Patientreported Outcomes
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0184Keywords:
atopic dermatitis, comorbidities, economic burden health-related quality of life, patient-reported outcomes, work productivityAbstract
Atopic dermatitis (AD) is a chronic skin disease associated with impaired quality of life. Evidence from Sweden on out-of-pocket expenses and productivity losses remains limited. This study assessed the burden of AD among adults in relation to health-related quality of life (HRQoL), work productivity, activity impairment, willingness to pay for symptom relief, economic outcomes, considering comorbid asthma, allergies, depression and anxiety. A cross-sectional survey was conducted between 2024 and 2025 among 220 members of the Swedish Asthma and Allergy Patient Association. Validated instruments included the Dermatology Life Quality Index (DLQI), EuroQol five-dimensions, five-levels instrument (EQ-5D-5L), Patient Benefit Index, and Work Productivity and Activity Impairment questionnaire. Descriptive and regression analyses were performed. Respondents (89.8% female; mean age 43 years) reported moderate HRQoL impairment (mean DLQI 10.1). DLQI and EQ-5D-5L were worse among those with allergic or non-atopic comorbidities but did not differ by asthma status. Mean annual out-of-pocket costs and productivity losses were €900 (95% CI: 401.1–1,758.4) and €1,972 (95% CI: 1,198.7–2,828.0), respectively. Itch intensity and activity impairment were associated with lower HRQoL and higher costs. AD is related to worsened work and activity functioning and high economic burden, suggesting the need for improved support and management strategies for affected adults.
Downloads
References
Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: adv00160. DOI: https://doi.org/10.2340/00015555-3510
Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 2018; 73: 1284–1293. DOI: https://doi.org/10.1111/all.13401
Sibbald C, Drucker AM. Patient burden of atopic dermatitis. Dermatol Clin 2017; 35: 303–316. DOI: https://doi.org/10.1016/j.det.2017.02.004
Theodosiou G, Montgomery S, Metsini A, Dalgard FJ, Svensson Å, Kobyletzki LB. Burden of atopic dermatitis in Swedish adults: a population-based study. Acta Derm Venereol 2019; 99: 964–970. DOI: https://doi.org/10.2340/00015555-3257
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134: 1527–1534. DOI: https://doi.org/10.1038/jid.2013.446
Silverberg JI, Anderson P, Cappelleri JC, Piercy J, Levenberg ME, Myers DE, et al. Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States. Arch Dermatol Res 2025; 317: 556. DOI: https://doi.org/10.1007/s00403-025-03910-y
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345–360. DOI: https://doi.org/10.1016/S0140-6736(20)31286-1
Smirnova J, Montgomery S, Lindberg M, Svensson Å, von Kobyletzki L. Associations of self-reported atopic dermatitis with comorbid conditions in adults: a population-based crosssectional study. BMC Dermatol 2020; 20: 23. DOI: https://doi.org/10.1186/s12895-020-00117-8
G, Sterner T, Hiyoshi A, Carlberg M, Svensson Å, Montgomery S, et al. Associations of atopic dermatitis in late adolescence with occupation, mental health, income from work and marital status: a national longitudinal study. Acta Derm Venereol 2025; 105: adv42127. DOI: https://doi.org/10.2340/actadv.v105.42127
Augustin M, Misery L, von Kobyletzki L, Armario-Hita JC, Mealing S, Redding M. Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol 2022; 36 Suppl 7: 3–16. DOI: https://doi.org/10.1111/jdv.18168
Beretzky Z, Koszorú K, Rencz F, Hajdu K, Borza J, Bodai K, et al. Societal costs and health related quality of life in adult atopic dermatitis. BMC Health Serv Res 2023; 23: 859. DOI: https://doi.org/10.1186/s12913-023-09840-7
Eyerich K, Gooderham MJ, Silvestre JF, Shumack SP, Mendes- Bastos P, Aoki V, et al. Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study. J Eur Acad Dermatol Venereol 2024; 38: 340–353. DOI: https://doi.org/10.1111/jdv.19500
Andersen L, Nyeland ME, Nyberg F. Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A. Br J Dermatol 2020; 182: 1007–1016. DOI: https://doi.org/10.1111/bjd.18296
Ezzedine K, Seneschal J, Corgibet F, Halioua B, Sampogna F, Merhand S, et al. The impact of atopic dermatitis on employment and productivity: a French study. Acta Derm Venereol 2025; 105: adv42734. DOI: https://doi.org/10.2340/actadv.v105.42734
Zink AGS, Arents B, Fink-Wagner A, Seitz IA, Mensing U, Wettemann N, et al. Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries. Acta Derm Venereol 2019; 99: 263–267. DOI: https://doi.org/10.2340/00015555-3102
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 4th ed. Oxford (UK): Oxford University Press; 2015.
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999; 141: 1067–1075. DOI: https://doi.org/10.1046/j.1365-2133.1999.03207.x
Beikert FC, Langenbruch AK, Radtke MA, Kornek T, Purwins S, Augustin M. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res 2014; 306: 279–286. DOI: https://doi.org/10.1007/s00403-013-1402-1
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a populationbased cross-sectional study. Ann Allergy Asthma Immunol 2018; 121: 340–347. DOI: https://doi.org/10.1016/j.anai.2018.07.006
Lundin S, Bergström A, Wahlgren CF, Johansson EK, Andersson N, Ballardini N, et al. Living with atopic dermatitis as a young adult in relation to health-related quality of life and healthcare contacts: a population-based study. Acta Derm Venereol 2022; 102: adv00702. DOI: https://doi.org/10.2340/actadv.v102.294
Johansson EK, Bergström A, Kull I, Melén E, Jonsson M, Lundin S, et al. Prevalence and characteristics of atopic dermatitis among young adult females and males-report from the Swedish population-based study BAMSE. J Eur Acad Dermatol Venereol 2022; 36: 698–704. DOI: https://doi.org/10.1111/jdv.17929
Ortsäter G, De Geer A, Rieem Dun A, Geale K, Lindberg I, Thyssen JP, et al. Societal economic burden and determinants of costs for atopic dermatitis. EADV Clin Pract 2022; 1: 326–343. DOI: https://doi.org/10.1002/jvc2.74
Johansson EK, Brenneche A, Trangbaek D, Stelmaszuk MN, Freilich J, Anderson CD. Treatment patterns among patients with atopic dermatitis in secondary care: a national, observational, non-interventional, retrospective study in Sweden. Acta Derm Venereol 2022; 102: adv00774. DOI: https://doi.org/10.2340/actadv.v102.1986
Ortsäter G, Geale K, Dun AR, Cappelleri JC, Cha A, Romero W, et al. Clinical and economic burden of pediatric mild-tomoderate atopic dermatitis: a population-based nested casecontrol study in Sweden. Dermatol Ther 2021; 11: 161–172. DOI: https://doi.org/10.1007/s13555-020-00470-z
Metsini A, Ryen L, Montgomery S, Svensson Å, Von Kobyletzki L. Healthcare visits, patterns of treatment, and related costs in children with controlled and uncontrolled atopic dermatitis in Sweden. Eur J Dermatol 2024; 34: 509–516. DOI: https://doi.org/10.1684/ejd.2024.4763
Niederberger M, Spranger J. Delphi technique in health sciences: a map. Front Public Health 2020; 8: 457. DOI: https://doi.org/10.3389/fpubh.2020.00457
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216. DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Institute for Health Services Research in Dermatology and Nursing (IVDP). Patient Benefit Index (PBI). University Medical Center Hamburg; 2023. [cited 2025 February 10]. Available from: https://www.patient-benefit-index.com/
Statistics Sweden (SCB). 2025. [cited 2025 February 1]. Available from: https://www.scb.se/en/finding-statistics/ statistics-by-subject-area/labour-market/wages-salaries-andlabour- costs/wage-and-salary-structures-and-employment-inthe- municipalities/pong/tables-and-graphs/average-monthlysalary- by-occupation/
Riksbank Sweden. 2025. [cited 2025 February 1]. Available from: https://www.riksbank.se/en-gb/statistics/interest-ratesand- exchange-rates/
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191–2194. DOI: https://doi.org/10.1001/jama.2013.281053
Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, White T, et al. Validation of patient-reported global severity of atopic dermatitis in adults. Allergy 2018; 73: 451–458. DOI: https://doi.org/10.1111/all.13309
Harmonising Outcome Measures for Eczema Initiative (HOME). 2024. [cited 2025 September 13]. Available from: https://www.homeforeczema.org/
EuroQol research foundation. 2024. [cited 2025 February 1]. Available from: https://euroqol.org/
Sun S, Chuang LH, Sahlén KG, Lindholm L, Norström F. Estimating a social value set for EQ-5D-5L in Sweden. Health Qual Life Outcomes 2022; 20: 167. DOI: https://doi.org/10.1186/s12955-022-02083-w
Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 497–501. DOI: https://doi.org/10.2340/00015555-1265
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353–365. DOI: https://doi.org/10.2165/00019053-199304050-00006
Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561–571. DOI: https://doi.org/10.1007/s00403-009-0928-8
Wintermann GB, Abraham S, Peters EMJ, Beissert S, Weidner K. Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis. Sci Rep 2025; 15: 1553. DOI: https://doi.org/10.1038/s41598-024-84794-2
Institute for Medical Technology Assessment (iMTA). Questionnaires for the measurement of costs in economic evaluations. 2023. [cited 2025 February 10]. Available from: https://www.imta.nl/questionnaires/
Additional Files
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
